• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼瞼 Merkel 細胞癌患者的放射治療有效初步治療。

An Effective Primary Treatment Using Radiotherapy in Patients with Eyelid Merkel Cell Carcinoma.

机构信息

CHU Lille, Department of Dermatology, University of Lille, F-59000 Lille, France.

Department of Medicine, University of Lille, H.Warembourg, F-59000 Lille, France.

出版信息

Curr Oncol. 2023 Jul 2;30(7):6353-6361. doi: 10.3390/curroncol30070468.

DOI:10.3390/curroncol30070468
PMID:37504328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10377768/
Abstract

BACKGROUND

Merkel cell carcinoma (MCC) is a rare type of neuroendocrine tumor. Palpebral localization represents 2.5% of MCCs. Surgery is not always possible due to the localization or comorbidities of elderly patients. We hypothesized that radiotherapy (RT) alone could be a curative treatment in patients contraindicated for oncological surgery.

METHODS

We performed a retrospective monocentric study of patients with localized eyelid MCC treated with curative intent using curative radiotherapy.

RESULTS

Overall, 11 patients with histologically confirmed eyelid MCC were treated with curative radiotherapy. The median age was 77 years old (range: 53-94). Curative RT was decided mainly due to difficult localization and significant co-morbidities. The median lesion dose was 57 Gy (range: 47-70). Most patients had adjuvant lymph nodes irradiation with a median dose of 50 Gy ( = 9; 82%). The median follow-up was 62 months (6-152 months). None of the seven deaths were MCC-related. None of our patients relapsed during follow-up. Side effects related to radiotherapy were mild (no grade ≥ 2) and rare ( = 3, 21%).

CONCLUSION

Our data suggest that curative radiotherapy is an effective and safe treatment for Merkel cell carcinoma of the eyelid and periocular region. Radiotherapy alone allows limiting the aesthetic and functional sequelae in elderly and comorbid patients who are contraindicated for oncological surgery.

摘要

背景

默克尔细胞癌(MCC)是一种罕见的神经内分泌肿瘤。眼睑定位占 MCC 的 2.5%。由于老年患者的定位或合并症,手术并非总是可行。我们假设单独放疗(RT)对于不适合肿瘤手术的患者可能是一种治愈性治疗。

方法

我们对接受根治性放疗治疗的局部眼睑 MCC 患者进行了回顾性单中心研究。

结果

共有 11 名经组织学证实的眼睑 MCC 患者接受了根治性放疗。中位年龄为 77 岁(范围:53-94)。根治性 RT 主要由于定位困难和严重合并症而决定。中位病变剂量为 57 Gy(范围:47-70)。大多数患者接受了辅助淋巴结照射,中位剂量为 50 Gy( = 9;82%)。中位随访时间为 62 个月(6-152 个月)。7 例死亡均与 MCC 无关。在随访期间,我们没有患者复发。放疗相关副作用轻微(无≥2 级)且罕见( = 3,21%)。

结论

我们的数据表明,根治性放疗是治疗眼睑和眼周区域默克尔细胞癌的有效且安全的方法。单独放疗可限制不适合肿瘤手术的老年和合并症患者的美容和功能后遗症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e168/10377768/7d1b78329637/curroncol-30-00468-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e168/10377768/9963699e4bb3/curroncol-30-00468-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e168/10377768/7d1b78329637/curroncol-30-00468-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e168/10377768/9963699e4bb3/curroncol-30-00468-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e168/10377768/7d1b78329637/curroncol-30-00468-g002.jpg

相似文献

1
An Effective Primary Treatment Using Radiotherapy in Patients with Eyelid Merkel Cell Carcinoma.眼瞼 Merkel 細胞癌患者的放射治療有效初步治療。
Curr Oncol. 2023 Jul 2;30(7):6353-6361. doi: 10.3390/curroncol30070468.
2
Outcome of early stage Merkel carcinoma treated by exclusive radiation: a study of 53 patients.早期 Merkel 细胞癌单纯放疗的疗效:53 例患者研究。
Radiat Oncol. 2021 May 14;16(1):90. doi: 10.1186/s13014-021-01815-4.
3
Merkel cell carcinoma of the eyelid: management and prognosis.眼睑 Merkel 细胞癌:治疗和预后。
JAMA Ophthalmol. 2014 Feb;132(2):197-204. doi: 10.1001/jamaophthalmol.2013.6077.
4
Identifying an Optimal Adjuvant Radiotherapy Dose for Extremity and Trunk Merkel Cell Carcinoma Following Resection: An Analysis of the National Cancer Database.确定肢体和躯干默克尔细胞癌切除术后的最佳辅助放疗剂量:来自美国国立癌症数据库的分析
JAMA Dermatol. 2017 Oct 1;153(10):1007-1014. doi: 10.1001/jamadermatol.2017.2176.
5
Outcomes of Merkel cell carcinoma treated with radiotherapy without radical surgical excision.未行根治性手术切除而接受放射治疗的默克尔细胞癌的治疗结果。
Ann Surg Oncol. 2014 Oct;21(11):3401-5. doi: 10.1245/s10434-014-3757-8. Epub 2014 Jul 8.
6
Impact of total radiotherapy dose on survival for head and neck Merkel cell carcinoma after resection.全放疗剂量对切除术后头颈部默克尔细胞癌生存的影响。
Head Neck. 2017 Jul;39(7):1371-1377. doi: 10.1002/hed.24776. Epub 2017 Mar 29.
7
Radiotherapy and Conservative Surgery in the Locoregional Management of Merkel Cell Carcinoma: The British Columbia Cancer Agency Experience.默克尔细胞癌局部区域治疗中的放射治疗与保守性手术:不列颠哥伦比亚癌症机构的经验
Ann Surg Oncol. 2016 Feb;23(2):573-8. doi: 10.1245/s10434-015-4812-9. Epub 2015 Aug 19.
8
Merkel cell carcinoma: improved outcome with adjuvant radiotherapy.默克尔细胞癌:辅助放疗改善预后。
ANZ J Surg. 2005 May;75(5):275-81. doi: 10.1111/j.1445-2197.2005.03353.x.
9
Adjuvant radiotherapy for Merkel cell carcinoma: A systematic review and meta-analysis.辅助放疗治疗 Merkel 细胞癌:系统评价和荟萃分析。
Radiother Oncol. 2019 May;134:211-219. doi: 10.1016/j.radonc.2019.02.015. Epub 2019 Feb 28.
10
Radiotherapy alone for primary Merkel cell carcinoma.原发性默克尔细胞癌单纯放疗
Arch Dermatol. 2003 Dec;139(12):1587-90. doi: 10.1001/archderm.139.12.1587.

引用本文的文献

1
Perform tumor-specific survival analysis for Merkel cell carcinoma patients undergoing surgical resection based on the SEER database by constructing a nomogram chart.基于监测、流行病学和最终结果(SEER)数据库,通过构建列线图对接受手术切除的默克尔细胞癌患者进行肿瘤特异性生存分析。
Open Med (Wars). 2025 Mar 21;20(1):20241103. doi: 10.1515/med-2024-1103. eCollection 2025.

本文引用的文献

1
Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - Update 2022. Merkel 细胞癌的诊断和治疗:基于欧洲共识的跨学科指南-2022 年更新。
Eur J Cancer. 2022 Aug;171:203-231. doi: 10.1016/j.ejca.2022.03.043. Epub 2022 Jun 19.
2
Outcome of early stage Merkel carcinoma treated by exclusive radiation: a study of 53 patients.早期 Merkel 细胞癌单纯放疗的疗效:53 例患者研究。
Radiat Oncol. 2021 May 14;16(1):90. doi: 10.1186/s13014-021-01815-4.
3
Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial.
CheckMate 358 试验中的可切除 Merkel 细胞癌患者的新辅助纳武利尤单抗治疗。
J Clin Oncol. 2020 Aug 1;38(22):2476-2487. doi: 10.1200/JCO.20.00201. Epub 2020 Apr 23.
4
Histogenesis of Merkel Cell Carcinoma: A Comprehensive Review.默克尔细胞癌的组织发生:全面综述
Front Oncol. 2019 Jun 10;9:451. doi: 10.3389/fonc.2019.00451. eCollection 2019.
5
Upper eyelid Merkel cell carcinoma treated with neoadjuvant chemotherapy and surgical excision.采用新辅助化疗和手术切除治疗的上睑默克尔细胞癌
Arch Craniofac Surg. 2019 Apr;20(2):121-125. doi: 10.7181/acfs.2018.02089. Epub 2019 Apr 20.
6
Merkel cell carcinoma of the eyelid: A review.眼睑 Merkel 细胞癌:综述。
Surv Ophthalmol. 2019 Sep-Oct;64(5):659-667. doi: 10.1016/j.survophthal.2019.03.002. Epub 2019 Mar 11.
7
Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. Merkel 细胞癌,1.2018 年版,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2018 Jun;16(6):742-774. doi: 10.6004/jnccn.2018.0055.
8
Change in Eyelid Carcinoma T Category With Use of the 8th Versus 7th Edition of the American Joint Committee on Cancer: Cancer Staging Manual.第 8 版与第 7 版美国癌症联合委员会癌症分期手册中眼睑癌 T 分类的变化。
Ophthalmic Plast Reconstr Surg. 2019 Jan/Feb;35(1):38-41. doi: 10.1097/IOP.0000000000001133.
9
Merkel cell carcinoma in France: a registries-based, comprehensive epidemiological survey.法国 Merkel 细胞癌:基于登记的全面流行病学调查。
J Eur Acad Dermatol Venereol. 2018 Aug;32(8):1292-1296. doi: 10.1111/jdv.14798. Epub 2018 Mar 9.
10
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.阿维鲁单抗治疗化疗难治性转移性默克尔细胞癌患者:一项多中心、单组、开放标签的2期试验。
Lancet Oncol. 2016 Oct;17(10):1374-1385. doi: 10.1016/S1470-2045(16)30364-3. Epub 2016 Sep 1.